Skip to main content
Caplight Logo









Arthro Biotech

Arthro Biotech

Private
HyderabadEnergy & Sustainabilityhttps://www.arthrobio.com/

Last Round

Grant

Oct 16, 2025

Total Funding Raised

$399,100

Company Overview

Arthro Biotech is an agritech company that produces sustainable insect-based ingredients for the animal feed and biotech industries using black soldier fly larvae.

Sector

Energy & Sustainability

Verticals

Circular Economy, Biotechnology, Waste Management, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

black soldier flyinsect proteininsect farmingBSF larvaeinsect mealsustainable animal feedbiofertilizerinsect oilaquafeedcircular economyagritechbioconversionalternative proteinbug proteininsect protein startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arthro Biotech Comparables

Compare Arthro Biotech with similar companies based on industry and business-model similarity.

Arthro Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GreenGrahi
93%
Keetup
91%
KovaiBSF
90%

Arthro Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 16, 2025
SeedMar 31, 2024
GrantNov 1, 2023
AcceleratorJun 1, 2023

Key People

Founding team and executive leadership

Praveen K Sappa

Arthro Biotech - Founder & CEO

Founding Team

Manikanth Injarapu

COO

Executive Team

Arthro Biotech Investors

Notable investors and investment history

Arthro Biotech investors
InvestorRounds
IKP Knowledge ParkAccelerator
Technology Development BoardGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 31, 2024

    $60K raised in Seed round.

  • Feb 1, 2024

    Grew 27% QoQ, from 11 to 14 employees.

Arthro Biotech Filings

Explore SEC and related filing metadata, where available.

Arthro Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Arthro Biotech's valuation, stock price, and market status.

Is Arthro Biotech a public or private company?

Arthro Biotech is a private company.

What is the current stock price of Arthro Biotech?

Arthro Biotech is a private company with no public stock price. Caplight tracks Arthro Biotech's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Arthro Biotech worth (valuation)?

Valuation information for Arthro Biotech is not publicly available.

Can I buy Arthro Biotech stock?

Arthro Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Arthro Biotech's last funding round?

Arthro Biotech's most recent funding round was Grant on October 16, 2025.

Who are the main investors in Arthro Biotech?

Key investors in Arthro Biotech include IKP Knowledge Park, Technology Development Board.

Will Arthro Biotech IPO soon?

No public IPO plans have been announced for Arthro Biotech.

How can I track Arthro Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arthro Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHyderabad
Employee Range11
Year Founded2023
Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?